US FDA

Provention Bio diabetes drug to cost $13,850/vial

Read more

Eugia Pharma receives US FDA nod for Amphotericin B Liposome Injection

Read more

US FDA issues warning letter to Lupin for Maharashtra-based API plant

Read more

US FDA extends review of Amicus muscle disorder therapy for second time

Read more

Three pharma companies recall products in US

Read more

US FDA issues four observations to Alembic Pharma’s Panelav plant

Read more

US health regulator extends review of Biogen’s ALS drug

Read more

US FDA asks Panacea Biotec to take corrective measures at Himachal unit

Read more

Aurobindo Pharma subsidiary’s plant gets one observation from US FDA

Read more

Glenmark, Strides Pharma and Cipla recall products in US

Read more